The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7525
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials ; volume:5 ; number:1 ; day:04 ; month:10 ; year:2007 ; pages:1-10 ; date:12.2007
Health and quality of life outcomes ; 5, Heft 1 (04.10.2007), 1-10, 12.2007
- Urheber
-
Dahlöf, Carl
Loder, Elizabeth
Diamond, Merle
Rupnow, Marcia
Papadopoulos, George
Mao, Lian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1477-7525-5-56
- URN
-
urn:nbn:de:101:1-2019071821170789302895
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dahlöf, Carl
- Loder, Elizabeth
- Diamond, Merle
- Rupnow, Marcia
- Papadopoulos, George
- Mao, Lian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials
Responder identification in clinical trials
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design
Strengthening the ethical assessment of placebo-controlled surgical trials: three proposals
Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Model validity of randomised placebo-controlled trials of individualised homeopathic treatment
Responder Identification in Clinical Trials with Censored Data
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials
Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials
Responder identification in clinical trials
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design
Strengthening the ethical assessment of placebo-controlled surgical trials: three proposals
Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Model validity of randomised placebo-controlled trials of individualised homeopathic treatment
Responder Identification in Clinical Trials with Censored Data
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials
Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials
Responder identification in clinical trials
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design
Strengthening the ethical assessment of placebo-controlled surgical trials: three proposals
Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Model validity of randomised placebo-controlled trials of individualised homeopathic treatment
Responder Identification in Clinical Trials with Censored Data
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials